Fulvestrant treatment is associated with cholesterol plasma level reduction in hormone-receptor-positive metastatic breast cancer patients.
Camerini A, Rondini M, Garrone O, Valsuani C, Donati S, Siclari O, Sgambato A, Tartarelli G, Vincenti M, Mattiot VP, Porta RP, Puccetti C, Puccinelli P, Amoroso D.
Camerini A, et al. Among authors: puccetti c.
Cancer Biol Ther. 2009 Aug;8(15):1450-5. doi: 10.4161/cbt.8.15.8959. Epub 2009 Aug 8.
Cancer Biol Ther. 2009.
PMID: 19556864
Free article.
Clinical Trial.